Navigation Links
Instrumentation Laboratory Introduces Automated HemosIL VWF Ristocetin Cofactor Activity Assay in Europe and International Regions
Date:11/29/2011

BEDFORD, Mass., Nov. 29, 2011 /PRNewswire/ -- Instrumentation Laboratory (IL) today announced the release of the new HemosIL von Willebrand Factor Ristocetin Cofactor Activity (VWF: RCo) assay as a European CE IVD Mark product under the European Directive on in vitro Diagnostic Medical Devices.  It will be commercialized in Europe and other international regions.  This new, fully automated VWF: RCo assay is for use on the ACL TOP® Family of Hemostasis Testing Systems. Together with other HemosIL reagents (HemosIL VWF Antigen, HemosIL VWF Activity, and HemosIL FVIII), it aids in the diagnosis and monitoring of von Willebrand Disease (VWD). 

(Logo:  http://photos.prnewswire.com/prnh/20100803/NE44435LOGO )

Based on new proprietary technology, the assay represents an innovative approach to VWD testing. Demonstrating excellent agreement with existing ristocetin-platelet-based tests, the HemosIL VWF: RCo assay eliminates platelet-associated variability.  The result is superior precision.  Additionally, variability associated with human interpretation, common with manual testing methods, is eliminated.  Moreover, because the assay is automated, liquid and ready-to-use, results are available in minutes and on-demand, 24/7. 

"This important new addition to our portfolio of VWF assays will help ensure early diagnosis and proper treatment for patients," said Remo Tazzi, Director, Hemostasis Marketing at IL.  "By simplifying and automating a complex procedure, the HemosIL VWF: RCo assay marks a significant improvement in not only the turnaround time for results, but also in accuracy and precision.  It is a perfect example of our commitment to providing specialized solutions for disease-state management."

About von Willebrand Disease

VWD is the most common inherited blood disorder, occurring in app
'/>"/>

SOURCE Instrumentation Laboratory
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Instrumentation Laboratory Receives FDA Clearance for HemosIL RecombiPlasTin 2G Assay
2. Instrumentation Laboratory Installs 2000th ACL TOP(R) System
3. Amerinet Awards Contract to Instrumentation Laboratory for Critical Care Portfolio
4. Instrumentation Laboratory Receives 510(K) Clearance From FDA and Canadian License for HemosIL(R) D-Dimer HS 500 Assay
5. Patient-Specific Surgical Instrumentation Expedites Total Knee Replacement Procedures
6. Instrumentation Laboratory Achieves Record Sales in 2009
7. Instrumentation Laboratory Receives FDA Clearance for New Automated Total Bilirubin Assay on GEM Premier 4000 Critical Care Analyzer
8. Instrumentation Laboratory Introduces Fully Automated, Liquid, Ready-to-Use HemosIL® HIT-Ab(PF4-H) Assay in Europe
9. Specialty Surgical Instrumentation Launches New Interactive Web Site
10. Instrumentation Laboratory to Host 2nd Asia Pacific Hemostasis Forum
11. Reportlinker Adds Global Ophthalmic Instrumentation Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... YORK , April 21, 2015 EpiCast ... Summary Sepsis is a life-threatening complication arising from ... the infection damages its own tissues and organs. Anyone ... among children <1 year of age, older ... 2014). Global estimates for the year 2013 showed that ...
(Date:4/21/2015)... -- Global cap & closure demand to ... and closures will exceed $55 billion in 2019. In unit ... Beverages will continue to account for well over half of ... smaller markets are expected to register faster growth. ... developed markets -- the US, Western Europe ...
(Date:4/21/2015)... 21, 2015 Gary A. Puckrein , ... Quality Forum (NMQF), today will present an award ... Pharmaceutical Research and Manufacturers of America (PhRMA), for ... On behalf of PhRMA, and in conjunction with NMQF, ... build awareness, start conversations, and increase diversity in clinical ...
Breaking Medicine Technology:EpiCast Report: Sepsis - Epidemiology Forecast to 2023 2EpiCast Report: Sepsis - Epidemiology Forecast to 2023 3World Caps & Closures Market 2World Caps & Closures Market 3National Minority Quality Forum to Award PhRMA President John Castellani for Leadership in Increasing Clinical Trial Diversity 2National Minority Quality Forum to Award PhRMA President John Castellani for Leadership in Increasing Clinical Trial Diversity 3
... Advanced Life Sciences,Holdings, Inc. (Nasdaq: ADLS ... with the National Institute of Allergy and ... biodefense,research, under which the NIAID will conduct ... as a treatment for,anthrax and other high-priority ...
... Double-Blind Study Targets Biomarker-Defined Population, BERKELEY ... GNTA ) announced that the first ... Phase 3 trial of Genasense,(oblimersen sodium) Injection ... is a randomized, double-blind, placebo-controlled study in ...
Cached Medicine Technology:Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 2Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 3Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 4Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma 2Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma 3Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma 4Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma 5
(Date:4/21/2015)... April 21, 2015 On April 2, ... Trying to Achieve Kylie Jenner Lips With ... have injured themselves while attempting an at-home lip ... Twitter is that creating an airlock around one’s mouth ... to plump and achieve Kylie Jenner’s now famous pout. ...
(Date:4/21/2015)... Texas (PRWEB) April 22, 2015 ... Review, H1 2015” provides comparative analysis on ... report strengthens R&D pipelines by identifying new ... best-in-class products. Complete report with TOC is ... The report also reviews key players involved ...
(Date:4/21/2015)... The California Healthcare Institute (CHI), ... sciences organizations, released the following statement by CHI ... Assembly Bill (AB) 463: , “As innovators in ... of treatments and cures for patients with serious ... AB 463, the so-called Pharmaceutical Cost Transparency Act ...
(Date:4/21/2015)... Vancouver, BC (PRWEB) April 21, 2015 ... offers complimentary pick-up and delivery for clients that avail ... South Surrey by Angelo’s is done with hi-tech equipments, ... inconvenience for customers. They use all natural, high pressure ... as well as hand washing for area rugs made ...
(Date:4/21/2015)... Danvers, MA (PRWEB) April 21, 2015 ... managed mobility services, has been recognized by the Boston ... Massachusetts. The ranking was announced at a recent ... Journal’s annual list of the fastest-growing private companies in ... held businesses in the state that recorded the fastest ...
Breaking Medicine News(10 mins):Health News:Celebrity Cosmetic Surgeon Comments on Report of Teen Girls Injuring Themselves Attempting Kylie Jenner-Inspired Twitter Challenge 2Health News:Pulmonary Embolism Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Pulmonary Embolism Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Pulmonary Embolism Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 4Health News:California Healthcare Institute Statement on AB 463 2Health News:California Healthcare Institute Statement on AB 463 3Health News:Angelo’s FabriClean Now Offers Area Rug Cleaning in South Surrey with Complimentary Pick-Up and Delivery 2Health News:Wireless Analytics Ranked as 25th Fastest Growing Private Company in Massachusetts 2
... 2 MedWaves, Inc. announces the receipt of ... is in addition to having already received U.S. ... Microwave Coagulation/Ablation System for surgical applications. The system ... interventional radiologists to treat soft tissue problems, such ...
... BEACH, Va., Feb. 2 AMERIGROUP Corporation (NYSE: ... plan in the State of Nevada began offering healthcare ... Children,s Health Insurance (SCHIP) programs beginning February 1, 2009. ... of Nevada," said James G. Carlson, AMERIGROUP Chairman and ...
... in customer and technical supportPORTLAND, Ore., Feb. 2 ... Vice President of Customer Support. With nearly 20 years ... managing customer inquiries, special service requests, and technical support ... leadership, she has also developed new programs to smooth ...
... Opportunity Partners, LLC ("Xmark"), the sole member of the investment ... Ltd., has, in the past, sent letters to the Board ... setting forth its dissatisfaction with the company,s corporate governance, management ... opportunity to respond to the Form 8-K filed by the ...
... Mich., Feb. 2 Dorothy Carpenter had stomach problems her ... or pasta could lead to terrible pain.Her illness went undiagnosed ... System physician recognized it as celiac disease. By then her ... forced doctors to remove part of her small intestine."I,ve been ...
... JOLLA, Calif., Feb. 2 Transdel Pharmaceuticals, ... ), a specialty pharmaceutical company focused on ... has retained FLP Pharma, a Georgia-based pharmaceutical ... especially the out-licensing of its lead product ...
Cached Medicine News:Health News:MedWaves, Inc. Announces Receipt of MDD CE Certification and Additional U.S. FDA 510(k) Clearance to Market Its Patented Microwave Coagulation/Ablation System and Devices 2Health News:AMERIGROUP Health Plan in Nevada Begins Serving Medicaid Enrollees 2Health News:GI Condition Once Thought Rare is Common in U.S. 2Health News:GI Condition Once Thought Rare is Common in U.S. 3Health News:Transdel Pharmaceuticals, Inc. Retains FLP Pharma to Lead Business Development Activities 2Health News:Transdel Pharmaceuticals, Inc. Retains FLP Pharma to Lead Business Development Activities 3
Rapid, visual assay for the presumptive qualitative detection of Respiratory Syncytial Virus (RSV) directly from nasopharyngeal specimens in neonatel and pediatric patients....
Rapid immunochromatographic membrane test for RSV. Accepts nasopharyngeal washes, aspirates, and swabs....
A direct enzyme immunoassay for detection of gr. A rotavirus in fecal specimens....
ELISA for Anti-Proteinase 3 PR3 (cANCA)....
Medicine Products: